US FDA declines to approve injection form of J&J's lung cancer drug-March 2024-www.financetom.com

US FDA declines to approve injection form of J&J's lung cancer drug

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA declines to approve injection form of J&J's lung cancer drug

Dec 16, 2024 1:18 PM

Dec 16 (Reuters) - The U.S. Food and Drug Administration

has declined to approve an injectable version of Johnson &

Johnson's ( JNJ ) drug Rybrevant for a type of lung cancer, the

drugmaker said on Monday.

Previous page： Hawaiian Electric lays out plan to reduce wildfire risk Next page： BlueLinx CFO Andrew Wamser Leaving Company

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Hawaiian Electric lays out plan to reduce wildfire risk

Jan 13, 2025

Jan 13 (Reuters) - Electricity provider Hawaiian Electric on Monday laid out a plan to fortify the power grid to help reduce the risk of a wildfire started by its equipment. The utility has faced intense scrutiny in the past for its role in the deadly 2023 Maui wildfire. The fires killed over 100 people, destroyed the historic coastal town...

BlueLinx CFO Andrew Wamser Leaving Company

Jan 13, 2025

05:49 PM EST, 01/13/2025 (MT Newswires) -- BlueLinx ( BXC ) said Monday that Chief Financial Officer Andrew Wamser is resigning from the company to take up another opportunity outside of the building products industry. His last day with the company will be Jan. 24, BlueLinx ( BXC ) said. It said Chief Accounting Officer Kimberly DeBrock will serve as...

Recursion Pharmaceuticals Insider Sold Shares Worth $287,200, According to a Recent SEC Filing

Jan 13, 2025

05:45 PM EST, 01/13/2025 (MT Newswires) -- Christopher Gibson, Director, Chief Executive Officer, on January 08, 2025, sold 40,000 shares in Recursion Pharmaceuticals ( RXRX ) for $287,200. Following the Form 4 filing with the SEC, Gibson has control over a total of 736,633 shares of the company, with 736,633 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1601830/000160183025000010/xslF345X05/wk-form4_1736807155.xml ...

Alamos Gold Lifts 2025 Production Guidance, Maintains 2026 Outlook

Jan 13, 2025

05:49 PM EST, 01/13/2025 (MT Newswires) -- Alamos Gold ( AGI ) said Monday it now expects total gold production of between 580,000 and 630,000 ounces for 2025, 7% higher than its previous guidance. The company maintained its production outlook for 2026 at 630,000 to 680,000 ounces, while setting a 2027 production guidance of 680,000 to 730,000 ounces. Alamos said...